USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection
- Posted on November 8, 2024
- By Financial Express
- 3 Views
USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection
Raltegravir Tablets USP, 600 mg (RLD Isentress HD) had an estimated annual sale of USD 36 million in the U.S. (IQVIA MAT September 2024).
